Roland Kratzer, et al. AASLD & Hepatology, October 2016 – DOI: 10.1002/hep.28800 Download the poster here Poster Presentation
Month: November 2016
Transgene presents preclinical results of TG1050, an HBV-targeted immunotherapy, at AASLD 2016 Liver Meeting
20161114-poster-hbv_aasld-en
Successful Completion of Transgene’s Rights Issue – Gross proceeds of circa €46.4 million
20161110 – TRANSGENE- Results PR